The global Urotropin for Injection market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
Urogonadotropin for injection for female infertility caused by hypogonadotropic or normogonadotropic ovarian insufficiency
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urotropin for Injection manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Urotropin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urotropin for Injection. This report contains market size and forecasts of Urotropin for Injection in global, including the following market information:
Global Urotropin for Injection market revenue, 2020-2025, 2026-2031, ($ millions)
Global Urotropin for Injection market sales, 2020-2025, 2026-2031, (K Units)
Global top five Urotropin for Injection companies in 2024 (%)
Total Market by Segment:
Global Urotropin for Injection market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Urotropin for Injection market segment percentages, by Type, 2024 (%)
75 Unit
150 Unit
Global Urotropin for Injection market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Urotropin for Injection market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Urotropin for Injection market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Urotropin for Injection market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urotropin for Injection revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Urotropin for Injection revenues share in global market, 2024 (%)
Key companies Urotropin for Injection sales in global market, 2020-2025 (estimated), (K Units)
Key companies Urotropin for Injection sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yantai Dongcheng North Pharmaceutical
Maanshan Fengyuan Pharmaceutical
Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd.
Ningbo Human Health Pharmaceutical Group
Livzon Group
Ningbo Human Health Pharmaceutical
Qingdao Kangyuan Pharmaceutical
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Ferring GmbH
IBSA Group
Merck
Livzon
Gedeon Richter
GenSci
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urotropin for Injection, market overview.
Chapter 2: Global Urotropin for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Urotropin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urotropin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Urotropin for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Urotropin for Injection Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Urotropin for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urotropin for Injection Overall Market Size
2.1 Global Urotropin for Injection Market Size: 2024 VS 2031
2.2 Global Urotropin for Injection Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Urotropin for Injection Sales: 2020-2031
3 Company Landscape
3.1 Top Urotropin for Injection Players in Global Market
3.2 Top Global Urotropin for Injection Companies Ranked by Revenue
3.3 Global Urotropin for Injection Revenue by Companies
3.4 Global Urotropin for Injection Sales by Companies
3.5 Global Urotropin for Injection Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Urotropin for Injection Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Urotropin for Injection Product Type
3.8 Tier 1, Tier 2, and Tier 3 Urotropin for Injection Players in Global Market
3.8.1 List of Global Tier 1 Urotropin for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Urotropin for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Urotropin for Injection Market Size Markets, 2024 & 2031
4.1.2 75 Unit
4.1.3 150 Unit
4.2 Segment by Type - Global Urotropin for Injection Revenue & Forecasts
4.2.1 Segment by Type - Global Urotropin for Injection Revenue, 2020-2025
4.2.2 Segment by Type - Global Urotropin for Injection Revenue, 2026-2031
4.2.3 Segment by Type - Global Urotropin for Injection Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Urotropin for Injection Sales & Forecasts
4.3.1 Segment by Type - Global Urotropin for Injection Sales, 2020-2025
4.3.2 Segment by Type - Global Urotropin for Injection Sales, 2026-2031
4.3.3 Segment by Type - Global Urotropin for Injection Sales Market Share, 2020-2031
4.4 Segment by Type - Global Urotropin for Injection Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Urotropin for Injection Market Size, 2024 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 Segment by Application - Global Urotropin for Injection Revenue & Forecasts
5.2.1 Segment by Application - Global Urotropin for Injection Revenue, 2020-2025
5.2.2 Segment by Application - Global Urotropin for Injection Revenue, 2026-2031
5.2.3 Segment by Application - Global Urotropin for Injection Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Urotropin for Injection Sales & Forecasts
5.3.1 Segment by Application - Global Urotropin for Injection Sales, 2020-2025
5.3.2 Segment by Application - Global Urotropin for Injection Sales, 2026-2031
5.3.3 Segment by Application - Global Urotropin for Injection Sales Market Share, 2020-2031
5.4 Segment by Application - Global Urotropin for Injection Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Urotropin for Injection Market Size, 2024 & 2031
6.2 By Region - Global Urotropin for Injection Revenue & Forecasts
6.2.1 By Region - Global Urotropin for Injection Revenue, 2020-2025
6.2.2 By Region - Global Urotropin for Injection Revenue, 2026-2031
6.2.3 By Region - Global Urotropin for Injection Revenue Market Share, 2020-2031
6.3 By Region - Global Urotropin for Injection Sales & Forecasts
6.3.1 By Region - Global Urotropin for Injection Sales, 2020-2025
6.3.2 By Region - Global Urotropin for Injection Sales, 2026-2031
6.3.3 By Region - Global Urotropin for Injection Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Urotropin for Injection Revenue, 2020-2031
6.4.2 By Country - North America Urotropin for Injection Sales, 2020-2031
6.4.3 United States Urotropin for Injection Market Size, 2020-2031
6.4.4 Canada Urotropin for Injection Market Size, 2020-2031
6.4.5 Mexico Urotropin for Injection Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Urotropin for Injection Revenue, 2020-2031
6.5.2 By Country - Europe Urotropin for Injection Sales, 2020-2031
6.5.3 Germany Urotropin for Injection Market Size, 2020-2031
6.5.4 France Urotropin for Injection Market Size, 2020-2031
6.5.5 U.K. Urotropin for Injection Market Size, 2020-2031
6.5.6 Italy Urotropin for Injection Market Size, 2020-2031
6.5.7 Russia Urotropin for Injection Market Size, 2020-2031
6.5.8 Nordic Countries Urotropin for Injection Market Size, 2020-2031
6.5.9 Benelux Urotropin for Injection Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Urotropin for Injection Revenue, 2020-2031
6.6.2 By Region - Asia Urotropin for Injection Sales, 2020-2031
6.6.3 China Urotropin for Injection Market Size, 2020-2031
6.6.4 Japan Urotropin for Injection Market Size, 2020-2031
6.6.5 South Korea Urotropin for Injection Market Size, 2020-2031
6.6.6 Southeast Asia Urotropin for Injection Market Size, 2020-2031
6.6.7 India Urotropin for Injection Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Urotropin for Injection Revenue, 2020-2031
6.7.2 By Country - South America Urotropin for Injection Sales, 2020-2031
6.7.3 Brazil Urotropin for Injection Market Size, 2020-2031
6.7.4 Argentina Urotropin for Injection Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Urotropin for Injection Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Urotropin for Injection Sales, 2020-2031
6.8.3 Turkey Urotropin for Injection Market Size, 2020-2031
6.8.4 Israel Urotropin for Injection Market Size, 2020-2031
6.8.5 Saudi Arabia Urotropin for Injection Market Size, 2020-2031
6.8.6 UAE Urotropin for Injection Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Yantai Dongcheng North Pharmaceutical
7.1.1 Yantai Dongcheng North Pharmaceutical Company Summary
7.1.2 Yantai Dongcheng North Pharmaceutical Business Overview
7.1.3 Yantai Dongcheng North Pharmaceutical Urotropin for Injection Major Product Offerings
7.1.4 Yantai Dongcheng North Pharmaceutical Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.1.5 Yantai Dongcheng North Pharmaceutical Key News & Latest Developments
7.2 Maanshan Fengyuan Pharmaceutical
7.2.1 Maanshan Fengyuan Pharmaceutical Company Summary
7.2.2 Maanshan Fengyuan Pharmaceutical Business Overview
7.2.3 Maanshan Fengyuan Pharmaceutical Urotropin for Injection Major Product Offerings
7.2.4 Maanshan Fengyuan Pharmaceutical Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.2.5 Maanshan Fengyuan Pharmaceutical Key News & Latest Developments
7.3 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd.
7.3.1 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Company Summary
7.3.2 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Business Overview
7.3.3 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Major Product Offerings
7.3.4 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.3.5 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Ningbo Human Health Pharmaceutical Group
7.4.1 Ningbo Human Health Pharmaceutical Group Company Summary
7.4.2 Ningbo Human Health Pharmaceutical Group Business Overview
7.4.3 Ningbo Human Health Pharmaceutical Group Urotropin for Injection Major Product Offerings
7.4.4 Ningbo Human Health Pharmaceutical Group Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.4.5 Ningbo Human Health Pharmaceutical Group Key News & Latest Developments
7.5 Livzon Group
7.5.1 Livzon Group Company Summary
7.5.2 Livzon Group Business Overview
7.5.3 Livzon Group Urotropin for Injection Major Product Offerings
7.5.4 Livzon Group Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.5.5 Livzon Group Key News & Latest Developments
7.6 Ningbo Human Health Pharmaceutical
7.6.1 Ningbo Human Health Pharmaceutical Company Summary
7.6.2 Ningbo Human Health Pharmaceutical Business Overview
7.6.3 Ningbo Human Health Pharmaceutical Urotropin for Injection Major Product Offerings
7.6.4 Ningbo Human Health Pharmaceutical Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.6.5 Ningbo Human Health Pharmaceutical Key News & Latest Developments
7.7 Qingdao Kangyuan Pharmaceutical
7.7.1 Qingdao Kangyuan Pharmaceutical Company Summary
7.7.2 Qingdao Kangyuan Pharmaceutical Business Overview
7.7.3 Qingdao Kangyuan Pharmaceutical Urotropin for Injection Major Product Offerings
7.7.4 Qingdao Kangyuan Pharmaceutical Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.7.5 Qingdao Kangyuan Pharmaceutical Key News & Latest Developments
7.8 Shanghai Tianwei Biopharmaceutical Co., Ltd.
7.8.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Summary
7.8.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
7.8.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Major Product Offerings
7.8.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.8.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Key News & Latest Developments
7.9 Ferring GmbH
7.9.1 Ferring GmbH Company Summary
7.9.2 Ferring GmbH Business Overview
7.9.3 Ferring GmbH Urotropin for Injection Major Product Offerings
7.9.4 Ferring GmbH Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.9.5 Ferring GmbH Key News & Latest Developments
7.10 IBSA Group
7.10.1 IBSA Group Company Summary
7.10.2 IBSA Group Business Overview
7.10.3 IBSA Group Urotropin for Injection Major Product Offerings
7.10.4 IBSA Group Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.10.5 IBSA Group Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Urotropin for Injection Major Product Offerings
7.11.4 Merck Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.11.5 Merck Key News & Latest Developments
7.12 Livzon
7.12.1 Livzon Company Summary
7.12.2 Livzon Business Overview
7.12.3 Livzon Urotropin for Injection Major Product Offerings
7.12.4 Livzon Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.12.5 Livzon Key News & Latest Developments
7.13 Gedeon Richter
7.13.1 Gedeon Richter Company Summary
7.13.2 Gedeon Richter Business Overview
7.13.3 Gedeon Richter Urotropin for Injection Major Product Offerings
7.13.4 Gedeon Richter Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.13.5 Gedeon Richter Key News & Latest Developments
7.14 GenSci
7.14.1 GenSci Company Summary
7.14.2 GenSci Business Overview
7.14.3 GenSci Urotropin for Injection Major Product Offerings
7.14.4 GenSci Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.14.5 GenSci Key News & Latest Developments
7.15 Teva
7.15.1 Teva Company Summary
7.15.2 Teva Business Overview
7.15.3 Teva Urotropin for Injection Major Product Offerings
7.15.4 Teva Urotropin for Injection Sales and Revenue in Global (2020-2025)
7.15.5 Teva Key News & Latest Developments
8 Global Urotropin for Injection Production Capacity, Analysis
8.1 Global Urotropin for Injection Production Capacity, 2020-2031
8.2 Urotropin for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Urotropin for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Urotropin for Injection Supply Chain Analysis
10.1 Urotropin for Injection Industry Value Chain
10.2 Urotropin for Injection Upstream Market
10.3 Urotropin for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Urotropin for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Urotropin for Injection in Global Market
Table 2. Top Urotropin for Injection Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Urotropin for Injection Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Urotropin for Injection Revenue Share by Companies, 2020-2025
Table 5. Global Urotropin for Injection Sales by Companies, (K Units), 2020-2025
Table 6. Global Urotropin for Injection Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Urotropin for Injection Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Urotropin for Injection Product Type
Table 9. List of Global Tier 1 Urotropin for Injection Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urotropin for Injection Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Urotropin for Injection Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Urotropin for Injection Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Urotropin for Injection Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Urotropin for Injection Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Urotropin for Injection Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Urotropin for Injection Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Urotropin for Injection Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Urotropin for Injection Sales, (K Units), 2026-2031
Table 21. By Region – Global Urotropin for Injection Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Urotropin for Injection Sales, (K Units), 2020-2025
Table 25. By Region - Global Urotropin for Injection Sales, (K Units), 2026-2031
Table 26. By Country - North America Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Urotropin for Injection Sales, (K Units), 2020-2025
Table 29. By Country - North America Urotropin for Injection Sales, (K Units), 2026-2031
Table 30. By Country - Europe Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Urotropin for Injection Sales, (K Units), 2020-2025
Table 33. By Country - Europe Urotropin for Injection Sales, (K Units), 2026-2031
Table 34. By Region - Asia Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Urotropin for Injection Sales, (K Units), 2020-2025
Table 37. By Region - Asia Urotropin for Injection Sales, (K Units), 2026-2031
Table 38. By Country - South America Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Urotropin for Injection Sales, (K Units), 2020-2025
Table 41. By Country - South America Urotropin for Injection Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Urotropin for Injection Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Urotropin for Injection Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Urotropin for Injection Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Urotropin for Injection Sales, (K Units), 2026-2031
Table 46. Yantai Dongcheng North Pharmaceutical Company Summary
Table 47. Yantai Dongcheng North Pharmaceutical Urotropin for Injection Product Offerings
Table 48. Yantai Dongcheng North Pharmaceutical Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Yantai Dongcheng North Pharmaceutical Key News & Latest Developments
Table 50. Maanshan Fengyuan Pharmaceutical Company Summary
Table 51. Maanshan Fengyuan Pharmaceutical Urotropin for Injection Product Offerings
Table 52. Maanshan Fengyuan Pharmaceutical Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Maanshan Fengyuan Pharmaceutical Key News & Latest Developments
Table 54. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Company Summary
Table 55. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Product Offerings
Table 56. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Ningbo Human Health Pharmaceutical Group Company Summary
Table 59. Ningbo Human Health Pharmaceutical Group Urotropin for Injection Product Offerings
Table 60. Ningbo Human Health Pharmaceutical Group Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Ningbo Human Health Pharmaceutical Group Key News & Latest Developments
Table 62. Livzon Group Company Summary
Table 63. Livzon Group Urotropin for Injection Product Offerings
Table 64. Livzon Group Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Livzon Group Key News & Latest Developments
Table 66. Ningbo Human Health Pharmaceutical Company Summary
Table 67. Ningbo Human Health Pharmaceutical Urotropin for Injection Product Offerings
Table 68. Ningbo Human Health Pharmaceutical Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Ningbo Human Health Pharmaceutical Key News & Latest Developments
Table 70. Qingdao Kangyuan Pharmaceutical Company Summary
Table 71. Qingdao Kangyuan Pharmaceutical Urotropin for Injection Product Offerings
Table 72. Qingdao Kangyuan Pharmaceutical Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Qingdao Kangyuan Pharmaceutical Key News & Latest Developments
Table 74. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Summary
Table 75. Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Product Offerings
Table 76. Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Shanghai Tianwei Biopharmaceutical Co., Ltd. Key News & Latest Developments
Table 78. Ferring GmbH Company Summary
Table 79. Ferring GmbH Urotropin for Injection Product Offerings
Table 80. Ferring GmbH Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Ferring GmbH Key News & Latest Developments
Table 82. IBSA Group Company Summary
Table 83. IBSA Group Urotropin for Injection Product Offerings
Table 84. IBSA Group Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. IBSA Group Key News & Latest Developments
Table 86. Merck Company Summary
Table 87. Merck Urotropin for Injection Product Offerings
Table 88. Merck Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Merck Key News & Latest Developments
Table 90. Livzon Company Summary
Table 91. Livzon Urotropin for Injection Product Offerings
Table 92. Livzon Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Livzon Key News & Latest Developments
Table 94. Gedeon Richter Company Summary
Table 95. Gedeon Richter Urotropin for Injection Product Offerings
Table 96. Gedeon Richter Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Gedeon Richter Key News & Latest Developments
Table 98. GenSci Company Summary
Table 99. GenSci Urotropin for Injection Product Offerings
Table 100. GenSci Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. GenSci Key News & Latest Developments
Table 102. Teva Company Summary
Table 103. Teva Urotropin for Injection Product Offerings
Table 104. Teva Urotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Teva Key News & Latest Developments
Table 106. Urotropin for Injection Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 107. Global Urotropin for Injection Capacity Market Share of Key Manufacturers, 2023-2025
Table 108. Global Urotropin for Injection Production by Region, 2020-2025 (K Units)
Table 109. Global Urotropin for Injection Production by Region, 2026-2031 (K Units)
Table 110. Urotropin for Injection Market Opportunities & Trends in Global Market
Table 111. Urotropin for Injection Market Drivers in Global Market
Table 112. Urotropin for Injection Market Restraints in Global Market
Table 113. Urotropin for Injection Raw Materials
Table 114. Urotropin for Injection Raw Materials Suppliers in Global Market
Table 115. Typical Urotropin for Injection Downstream
Table 116. Urotropin for Injection Downstream Clients in Global Market
Table 117. Urotropin for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Urotropin for Injection Product Picture
Figure 2. Urotropin for Injection Segment by Type in 2024
Figure 3. Urotropin for Injection Segment by Application in 2024
Figure 4. Global Urotropin for Injection Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Urotropin for Injection Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Urotropin for Injection Revenue: 2020-2031 (US$, Mn)
Figure 8. Urotropin for Injection Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Urotropin for Injection Revenue in 2024
Figure 10. Segment by Type – Global Urotropin for Injection Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Urotropin for Injection Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Urotropin for Injection Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Urotropin for Injection Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Urotropin for Injection Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Urotropin for Injection Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Urotropin for Injection Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Urotropin for Injection Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Urotropin for Injection Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Urotropin for Injection Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Urotropin for Injection Revenue Market Share, 2020-2031
Figure 21. By Region - Global Urotropin for Injection Sales Market Share, 2020-2031
Figure 22. By Country - North America Urotropin for Injection Revenue Market Share, 2020-2031
Figure 23. By Country - North America Urotropin for Injection Sales Market Share, 2020-2031
Figure 24. United States Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Urotropin for Injection Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Urotropin for Injection Sales Market Share, 2020-2031
Figure 29. Germany Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 30. France Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Urotropin for Injection Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Urotropin for Injection Sales Market Share, 2020-2031
Figure 38. China Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 42. India Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Urotropin for Injection Revenue Market Share, 2020-2031
Figure 44. By Country - South America Urotropin for Injection Sales, Market Share, 2020-2031
Figure 45. Brazil Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Urotropin for Injection Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Urotropin for Injection Sales, Market Share, 2020-2031
Figure 49. Turkey Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Urotropin for Injection Revenue, (US$, Mn), 2020-2031
Figure 53. Global Urotropin for Injection Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Urotropin for Injection by Region, 2024 VS 2031
Figure 55. Urotropin for Injection Industry Value Chain
Figure 56. Marketing Channels
